Preclinical drug development (31 Ergebnisse)

Hardcover. Zustand: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

hardcover. Zustand: Sehr gut. 465 Seiten; 9781588292285.2 Gewicht in Gramm: 2.

Zustand: New. In English.

Zustand: fine. 2012, 218pp, Paperback in goede staat.

Zustand: New. pp. 256.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New. In English.

Hardcover. Zustand: Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Zustand: New. pp. 290.

Zustand: New. In English.

Paperback. Zustand: Brand New. 256 pages. 9.21x6.14x0.55 inches. In Stock.

Zustand: New. In English.

Taschenbuch. Zustand: Neu. Anticancer Drug Development Guide | Preclinical Screening, Clinical Trials, and Approval | Beverly A. Teicher | Taschenbuch | Cancer Drug Discovery and Development | xii | Englisch | 2013 | Humana | EAN 9781461581543 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Zustand: New. Chao Han, PHD, is Associate Director of Pharmacokinetics, Modeling and Simulation, Clinical Pharmacology Sciences, Centocor R&D. He has been working in drug discovery and early development for more than ten years, published over thirty research articles in .

Hardcover. Zustand: Brand New. new edition. 464 pages. 9.45x6.50x0.83 inches. In Stock.

Zustand: New. In English.

Zustand: New. Explaining the assessment of potential drug compounds, this is an ideal introductory reference for those new to drug discovery. It includes sections on pharmacokinetics and drug metabolism, integration of pharmaceutical development, and predictive safety assessment. Editor(s): Han, Chao; Davis, Charles B.; Wang, Binghe. Series: Wiley Series in Drug Discovery and Development. Num Pages: 290 pages, Illustrations (some col.). BIC Classification: MBGR1. Category: (P) Professional & Vocational. Dimension: 240 x 159 x 20. Weight in Grams: 556. . 2010. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. …

Taschenbuch. Zustand: Neu. Anticancer Drug Development Guide | Preclinical Screening, Clinical Trials, and Approval | Beverly A. Teicher (u. a.) | Taschenbuch | Cancer Drug Discovery and Development | xiv | Englisch | 2012 | Humana | EAN 9781468498417 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Buch. Zustand: Neu. Neuware - Emphasizes the integration of major areas of drug discovery and their importance in candidate evaluation It is believed that selecting the 'right' drug candidate for development is the key to success. In the last decade, pharmaceutical R&D departments have integrated pharmacokinetics and drug metabolism, pharmaceutics, and toxicology into early drug discovery to improve the assessment of potential drug compounds. Now, Evaluation of Drug Candidates for Preclinical Development provides a complete view and understanding of why absorption-distribution-metabolism-excretion-toxicology (ADMET) plays a pivotal role in drug discovery and development. Encompassing the three major interrelated areas in which optimization and evaluation of drug developability is most critical?pharmacokinetics and drug metabolism, pharmaceutics, and safety assessment?this unique resource encourages integrated thinking in drug discovery. The contributors to this volume: - Cover drug transporters, cytochrome P-450 and drug-drug interactions, plasma protein binding, stability, drug formulation, preclinical safety assessment, toxicology, and toxicokinetics - Address developability issues that challenge pharma companies, moving beyond isolated experimental results - Reveal connections between the key scientific areas that are critical for successful drug discovery and development - Inspire forward-thinking strategies and decision-making processes in preclinical evaluation to maximize the potential of drug candidates to progress through development efficiently and meet the increasing demands of the marketplace Evaluation of Drug Candidates for Preclinical Development serves as an introductory reference for those new to the pharmaceutical industry and drug discovery in particular. It is especially well suited for scientists and management teams in small- to mid-sized pharmaceutical companies, as well as academic researchers and graduate students concerned with the practical aspects related to the evaluation of drug developability.…

Taschenbuch. Zustand: Neu. Preclinical cancer models for translational research and drug development | Suresh P. K. (u. a.) | Taschenbuch | xi | Englisch | 2026 | Springer | EAN 9789819757442 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides updated information on certain in vitro and preclinical in vivo cancer models. The topics covered include an update on advancements in the diagnosis, treatment and heterogeneity in certain cancers; the development of preclinical in vitro and xenograft-based in vivo cancer models as well as their validation based on widely accepted biomarkers; modelling of aberrations in bioenergetics in cancers. Also, the importance and latest advances of in silico modeling for the design of new and potent anti-cancer drugs has been reviewed. Cutting-edge and resourceful, this book is valuable for researchers, academicians, and professionals involved in cancer research.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides updated information on certain in vitro and preclinical in vivo cancer models. The topics covered include an update on advancements in the diagnosis, treatment and heterogeneity in certain cancers; the development of preclinical in vitro and xenograft-based in vivo cancer models as well as their validation based on widely accepted biomarkers; modelling of aberrations in bioenergetics in cancers. Also, the importance and latest advances of in silico modeling for the design of new and potent anti-cancer drugs has been reviewed. Cutting-edge and resourceful, this book is valuable for researchers, academicians, and professionals involved in cancer research.…

Paperback. Zustand: Brand New. reprint edition. 465 pages. 9.75x7.00x1.25 inches. In Stock.

Zustand: New. In English.

Hardcover. Zustand: Brand New. 179 pages. 9.25x6.10x9.49 inches. In Stock.

Gebunden. Zustand: New. Mark Rogge, David R. TaftPreclinical Drug Development, Second Edition discusses the broad and complicated realm of preclinical drug development. Topics range from assessment of pharmacology and toxicology to industry trends and regul.

Zustand: New. In English.

Zustand: New.

Hardcover. Zustand: Brand New. 1st edition. 238 pages. 9.75x6.50x0.75 inches. In Stock.